Encyclopedia of Malaria

Living Edition
| Editors: Peter G. Kremsner, Sanjeev Krishna

Blood Bank Screening

  • Imelda Bates
  • Alex Owusu-Ofori
Living reference work entry
DOI: https://doi.org/10.1007/978-1-4614-8757-9_103-1



Blood bank screening is the process of evaluating donated blood/blood components to ensure that the blood/blood component obtained is free of any transmissible pathogen. Screening usually involves a combination of an interview-based donor selection process and a series of laboratory-based testing of blood.

Blood transfusion safety is an important public health concern worldwide. The deferral of blood donors who are found to have positive screening tests for transfusion-transmitted infections has contributed immensely to the availability of safe blood. Currently, the World Health Organization (WHO) recommends that as a minimum, blood should be screened for HIV, hepatitis B (HBV), hepatitis C (HCV), and syphilis (World Health Organisation 2010b). Unfortunately even this minimum recommendation is not fully carried out in some developing countries so blood safety remains an important issue (Tagny et al. 2008).



Malaria Parasite Blood Donor Indirect Fluorescent Antibody Test Malaria Parasitemia Presumptive Treatment 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
This is a preview of subscription content, log in to check access.


  1. Achidi EA, Perlmann H, Berzins K. Asymptomatic malaria parasitaemia and seroreactivities to Plasmodium falciparum antigens in blood donors from Ibadan, south-western Nigeria. Ann Trop Med Parasitol. 1995;89(6):601–10.PubMedGoogle Scholar
  2. Atchade PS, Doderer-Lang C, Chabi N, Perrotey S, Abdelrahman T, Akpovi CD, Anani L, Bigot A, Sanni A, Candolfi E. Is a Plasmodium lactate dehydrogenase (pLDH) enzyme-linked immunosorbent (ELISA)-based assay a valid tool for detecting risky malaria blood donations in Africa? Malar J. 2013; 12:279.PubMedCentralPubMedCrossRefGoogle Scholar
  3. Bates I, Chapotera GK, McKew S, Van Den Broek N. Maternal mortality in sub-Saharan Africa: the contribution of ineffective blood transfusion services. BJOG: Int J Obstet Gynaecol. 2008;115(11):1331–9.CrossRefGoogle Scholar
  4. Bjorkman A, Perlmann H, Petersen E, Hogh B, Lebbad M, Warsame M, Hanson AP, Perlmann P. Consecutive determinations of seroreactivities to Pf155/RESA antigen and to its different repetitive sequences in adult men from a holoendemic area of Liberia. Parasite Immunol. 1990;12(2):115–23.PubMedCrossRefGoogle Scholar
  5. Bloch EM, Vermeulen M, Murphy E. Blood transfusion safety in Africa: a literature review of infectious disease and organizational challenges. Transfus Med Rev. 2012;26(2):164–80. doi:10.1016/j.tmrv.2011.07.006.PubMedCentralPubMedCrossRefGoogle Scholar
  6. Chattopadhyay R, Majam VF, Kumar S. Survival of Plasmodium falciparum in human blood during refrigeration. Transfusion. 2011;51(3):630–5.PubMedCrossRefGoogle Scholar
  7. Cheng A, Bell D. Evidence behind the WHO guidelines: hospital care for children: what is the precision of rapid diagnostic tests for malaria? J Trop Pediatr. 2006;52(6):386–9.PubMedCrossRefGoogle Scholar
  8. Diop S, Ndiaye M, Seck M, Chevalier B, Jambou R, Sarr A, Dièye TN, Touré AO, Thiam D, Diakhaté L. Prevention of transfusion transmitted malaria in endemic area. Transfus Clin Biol. 2009;16(5–6):454–9.PubMedCrossRefGoogle Scholar
  9. El Chaar M, Atwal S, Freimanis GL, Dinko B, Sutherland CJ, Allain JP. Inactivation of Plasmodium falciparum in whole blood by riboflavin plus irradiation. Transfusion. 2013. doi:10.1111/trf.12235.PubMedGoogle Scholar
  10. Faddy HM, Seed CR, Faddy MJ, Flower RL, Harley RJ. Malaria antibody persistence correlates with duration of exposure. Vox Sang. 2013;104(4):292–8.PubMedCrossRefGoogle Scholar
  11. Garraud O, Assal A, Pelletier B, Danic B, Kerleguer A, David B, Joussemet M, De Micco P. Overview of revised measures to prevent malaria transmission by blood transfusion in France. Vox Sang. 2008;95(3):226–31.PubMedCrossRefGoogle Scholar
  12. Hanscheid T, Valadas E, Grobusch MP. Polymerase chain reaction for screening blood donors at risk for malaria: safe and useful? Emerg Infect Dis. 2002;8(8):872; author reply 873–4.PubMedCentralPubMedCrossRefGoogle Scholar
  13. Kano S, Kimura M. Trends in malaria cases in Japan. Acta Trop. 2004;89(3):271–8.PubMedCrossRefGoogle Scholar
  14. Kitchen AD, Chiodini PL. Malaria and blood transfusion. Vox Sang. 2006;90(2):77–84.PubMedCrossRefGoogle Scholar
  15. Makler MT, Hinrichs DJ. Measurement of the lactate dehydrogenase activity of Plasmodium falciparum as an assessment of parasitemia. Am J Trop Med Hyg. 1993;48(2):205–10.PubMedGoogle Scholar
  16. Marschner S, Goodrich R. Pathogen reduction technology treatment of platelets, plasma and whole blood using riboflavin and UV light. Transfus Med Hemother. 2011;38(1):8–18.PubMedCentralPubMedCrossRefGoogle Scholar
  17. Moody A. Rapid diagnostic tests for malaria parasites. Clin Microbiol Rev. 2002;15(1):66–78.PubMedCentralPubMedCrossRefGoogle Scholar
  18. Oduola AMJ, Omitowoju GO, Sowunmi A, Makler MT, Falade CO, Kyle DE, Fehintola FA, Ogundahunsi OAT, Piper RC, Schuster BG, Milhous WK. Plasmodium falciparum: evaluation of lactate dehydrogenase in monitoring therapeutic responses to standard antimalarial drugs in Nigeria. Exp Parasitol. 1997;87(3):283–9.PubMedCrossRefGoogle Scholar
  19. Owusu-Ofori AK, Parry C, Bates I. Transfusion-transmitted malaria in countries where malaria is endemic: a review of the literature from sub-Saharan Africa. Clin Infect Dis. 2010;51(10):1192–8.PubMedCrossRefGoogle Scholar
  20. Owusu-Ofori AK, Betson M, Parry CM, Stothard JR, Bates I. Transfusion-transmitted malaria in Ghana. Clin Infect Dis. 2013;56(12):1735–41.PubMedCrossRefGoogle Scholar
  21. Reesink HW, Panzer S, Wendel S, Levi JE, Ullum H, Ekblom-Kullberg S, Seifried E, Schmidt M, Shinar E, Prati D, Berzuini A, Ghosh S, Flesland Ø, Jeansson S, Zhiburt E, Piron M, Sauleda S, Ekermo B, Eglin R, Kitchen A, Dodd RY, Leiby DA, Katz LM, Kleinman S. The use of malaria antibody tests in the prevention of transfusion- transmitted malaria. Vox Sang. 2010;98(3 PART. 2):468–78.PubMedCrossRefGoogle Scholar
  22. Roback JD. Vascular effects of the red blood cell storage lesion. Hematol/Educ Prog Am Soc Hematol Am Soc Hematol Educ Prog. 2011;2011:475–9.CrossRefGoogle Scholar
  23. Seed CR, Kitchen A, Davis TM. The current status and potential role of laboratory testing to prevent transfusion-transmitted malaria. Transfus Med Rev. 2005;19(3):229–40.PubMedCrossRefGoogle Scholar
  24. SHOT, Working group. Serious hazards of transfusion annual report 2010. Manchester: Serious Hazards of Transfusion (SHOT); 2011.Google Scholar
  25. Tagny CT, Mbanya D, Tapko JB, LefreÌ€re JJ. Blood safety in Sub-Saharan Africa: a multi-factorial problem. Transfusion. 2008;48(6):1256–61.PubMedCrossRefGoogle Scholar
  26. Van Der Sluis JJ, Ten Kate FJW, Vuzevski VD. Transfusion syphilis, survival of Treponema pallidum in stored donor blood. II. Dose dependence of experimentally determined survival times. Vox Sang. 1985;49(6):390–9.PubMedCrossRefGoogle Scholar
  27. World Health Organisation. Guidelines for the treatment of malaria. Geneva: WHO; Geneva, Switzerland. 2010a.Google Scholar
  28. World Health Organisation. Screening donated blood for transfusion-transmissible infections; recommendations. WHO; Geneva, Switzerland. 2010b.Google Scholar

Copyright information

© Springer Science+Business Media New York 2014

Authors and Affiliations

  1. 1.Liverpool School of Tropical MedicineLiverpoolUK
  2. 2.Komfo Anokye Teaching Hospital/Kwame Nkrumah University of Science and TechnologyKumasiGhana